Walleye Capital’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Walleye Capital’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-463,347	Closed	-$23.2K	–	5756
2023 Q3	$23.2K	Buy	463,347 +229,800	+98%	+$31.2K	﹤0.01%	4362
2023 Q2	$49.1K	Hold	233,547	–	–	﹤0.01%	3643
2023 Q1	$37.4K	Buy	233,547 +8,768	+4%	+$2.58K	﹤0.01%	3270
2022 Q4	$49.5K	Buy	224,779 +160,167	+248%	+$139K	﹤0.01%	2524
2022 Q3	$171K	Sell	64,612 -580,961	-90%	-$855K	﹤0.01%	2198
2022 Q2	$439K	Buy	645,573 +166,591	+35%	+$173K	0.01%	1110
2022 Q1	$757K	Sell	478,982 -702,343	-59%	-$1.01M	0.02%	774
2021 Q4	$2.82M	Buy	1,181,325 +375,280	+47%	+$1.14M	0.09%	251
2021 Q3	$3.33K	Buy	806,045 +600,341	+292%	+$2.26M	0.09%	146
2021 Q2	$759	Buy	+205,704	New	+$929K	0.03%	563

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Walleye Capital's CANO.WS Position: Q4 2023 in Review

Walleye Capital sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 463,347 shares — an estimated $23.2K sold.

Walleye Capital first reported a position in CANO.WS in Q2 2021 and held it in 10 quarters. The position peaked at $2.82M in Q4 2021. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

Walleye Capital reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
Walleye Capital sold 463,347 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $23.2K.
Walleye Capital first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 10 quarters.
Walleye Capital's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $2.82M in Q4 2021.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.